首页> 外文OA文献 >Mikania micrantha Extract Inhibits HMG-CoA Reductase and ACAT2 and Ameliorates Hypercholesterolemia and Lipid Peroxidation in High Cholesterol-Fed Rats
【2h】

Mikania micrantha Extract Inhibits HMG-CoA Reductase and ACAT2 and Ameliorates Hypercholesterolemia and Lipid Peroxidation in High Cholesterol-Fed Rats

机译:Mikania Mictha提取物抑制HMG-CoA还原酶和ACAT2,并在高胆固醇喂养大鼠中改善高胆固醇血症和脂质过氧化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study aimed to determine the effect of an ethyl acetate extract of Mikaniamicrantha stems (EAMMS) in hypercholesterolemia-induced rats. Rats were divided into a normal group (NC) and hypercholesterolemia induced groups: hypercholesterolemia control group (PC), simvastatin group (SV) (10 mg/kg) and EAMMS extract groups at different dosages of 50, 100 and 200 mg/kg, respectively. Blood serum and tissues were collected for haematological, biochemical, histopathological, and enzyme analysis. Total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), aspartate aminotransferase (AST), alanine aminotransferase (ALT), urea, creatinine, malondialdehyde (MDA) level, as well as enzymes of HMG-CoA reductase (HMGCR) and acetyl-CoA acetyltransferase 2 (ACAT2), were measured. Feeding rats with high cholesterol diet for eight weeks resulted in a significantly (p<0.05) increased of TC, TG, LDL-C, AST, ALT and MDA levels. Meanwhile, the administration of EAMMS extract (50, 100 and 200 mg/kg) and simvastatin (10 mg/kg) significantly reduced (p<0.05) the levels of TC, TG, LDL-C and MDA compared to rats in the PC group. Furthermore, all EAMMS and SV-treated groups showed a higher HDL-C level compared to both NC and PC groups. No significant difference was found in the level of ALT, AST, urea and creatinine between the different dosages in EAMMS extracts. Treatment with EAMMS also exhibited the highest inhibition activity of enzyme HMGCR and ACAT2 as compared to the control group. From the histopathological examination, liver tissues in the PC group showed severe steatosis than those fed with EAMMS and normal diet. Treatment with EAMMS extract ameliorated and reduced the pathological changes in the liver. No morphological changes showed in the kidney structure of both control and treated groups. In conclusion, these findings demonstrated that EAMMS extract has anti-hypercholesterolemia properties and could be used as an alternative treatment for this disorder.
机译:本研究旨在确定Mikaniamcrantha茎(EAMMS)乙酸乙酯提取物在高胆固醇血症诱导的大鼠中的作用。将大鼠分为正常组(NC)和高胆固醇血症诱导的组:高胆固醇血症对照组(PC),辛伐他汀组(SV)(10mg / kg)和EAMMS提取基团,不同剂量为50,100和200 mg / kg,分别。收集血清和组织用于血液学,生物化学,组织病理学和酶分析。总胆固醇(TC),甘油三酯(Tg),低密度脂蛋白胆固醇(LDL-C),高密度脂蛋白胆固醇(HDL-C),天冬氨酸氨基转移酶(AST),丙氨酸氨基转移酶(ALT),尿素,肌酐,丙二醛(MDA)水平以及HMG-COA还原酶(HMGCR)和乙酰-COA乙酰转移酶2(ACAT2)的酶。含有高胆固醇饮食八周的喂养大鼠显着(P <0.05)增加TC,TG,LDL-C,AST,ALT和MDA水平。同时,与PC中的大鼠相比,EAMMS提取物(50,100和200mg / kg)和辛伐他汀(10mg / kg)的施用显着降低(p <0.05)Tc,Tg,Ldl-c和MDA的水平团体。此外,与NC和PC组相比,所有EAMM和SV治疗组都显示出更高的HDL-C电平。在EAMMS提取物中不同剂量之间的ALT,AST,尿素和肌酐水平没有显着差异。与对照组相比,EAMMS的处理也表现出酶HMGCR和ACAT2的最高抑制活性。从组织病理学检查中,PC组中的肝组织显示出严重的脂肪变性,而不是EAMMS和正常饮食的脂肪变性。用EAMMS提取物治疗改善并降低了肝脏的病理变化。对照组和治疗组的肾脏结构没有形态变化。总之,这些研究结果表明,EAMMS提取物具有抗高胆固醇血症性质,可用作这种疾病的替代治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号